首页> 美国卫生研究院文献>Radiology Case Reports >Incidentally detected cardiac amyloidosis on 99mTc-MDP bone scintigraphy
【2h】

Incidentally detected cardiac amyloidosis on 99mTc-MDP bone scintigraphy

机译:在99mTc-MDP骨显像仪上偶然发现心脏淀粉样变性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cardiac amyloidosis (CA) is an important cause of restrictive cardiomyopathy and heart failure with preserved ejection fraction (HFpEF). At present, 3 bone-seeking tracers, Tc-diphosphono-1,2-propanodicarboxylic acid ( Tc-DPD), Tc-pyrophosphate ( Tc-PYP), and Tc-hydroxymethylene diphosphonate ( Tc-HMDP), have been evaluated for detecting CA, but they are not widely available. In contrast, methylene diphosphate (MDP) is widely available. However, only sporadic case reports have shown that MDP can accumulate in patients with CA. We report an 86-year-old man with multiple medical problems, including hypertension, hyperlipidemia, HFpEF, and a history of treated prostate cancer, who was referred for a Tc-MDP bone scan to rule out bone metastasis. The bone scan was negative for bone metastasis, but there was mild tracer accumulation in the heart, suggestive of CA. Subsequently, CA was diagnosed on Tc-PYP imaging. MDP may play a role comparable to other bone-seeking tracers in the diagnosis of CA and may be used as a noninvasive adjunct in the diagnosis of CA. Future research should compare MDP with other bone-seeking tracers for the diagnosis of CA. In addition, mechanistic studies on tracer binding to amyloid fibrils may help understand the pathophysiology of CA and facilitate the development of better and more specific tracers for CA.
机译:心脏淀粉样变性病(CA)是限制性心肌病和心力衰竭的重要原因,其射血分数(HFpEF)保持不变。目前,已经评估了3种寻骨示踪剂Tc-二膦酰基1,2-丙二羧酸(Tc-DPD),Tc-焦磷酸盐(Tc-PYP)和Tc-羟基亚甲基二膦酸酯(Tc-HMDP) CA,但它们并不广泛可用。相反,二磷酸二甲酯(MDP)广泛可用。但是,只有零星的病例报告显示MDP可以在CA患者中蓄积。我们报道了一个86岁的男子,他患有多种医疗问题,包括高血压,高脂血症,HFpEF和已治疗的前列腺癌病史,该病被推荐进行Tc-MDP骨扫描以排除骨转移。骨扫描显示骨转移阴性,但心脏中有少量示踪剂蓄积,提示CA。随后,在Tc-PYP成像中诊断出CA。 MDP在CA的诊断中可以起到与其他寻骨示踪剂相当的作用,并且可以在CA的诊断中用作无创辅助剂。未来的研究应将MDP与其他寻骨示踪剂进行比较,以诊断CA。此外,有关示踪剂与淀粉样蛋白原纤维结合的机理研究可能有助于了解CA的病理生理,并有助于开发更好,更特异性的CA示踪剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号